Target intelligence / Profile preview

Tumor suppressor 2, mitochondrial calcium regulator (TUSC2)

Target
TUSC2
Molecular classification
Tumor suppressor gene, Mitochondrial calcium regulator, Other (does not fit typical receptor, enzyme, transporter, or ion channel families)
01

Overview

Tumor suppressor 2, mitochondrial calcium regulator (TUSC2, also known as FUS1), is a highly conserved tumor suppressor gene located at 3p21.31 in the human genome. It encodes a 110-amino acid protein with key motifs, including myristoylation and EF-hand calcium binding domains, enabling regulation of mitochondrial calcium, apoptosis, and cell cycle. TUSC2 is ubiquitously expressed, with loss of function implicated in a broad spectrum of cancers; its restoration promotes apoptosis and suppresses tumor growth. TUSC2 also modulates immune pathways and cellular stress responses, is under study as a target for systemic gene therapy in cancer, and participates in post-translational modifications such as myristoylation and ubiquitination which dictate its cellular stability. Its pseudogenes, regulatory mechanisms, and broad involvement in disease make TUSC2 a promising target for therapeutic intervention, especially in cancers with 3p21.3 deletions.

Other names
FUS1PDAP2PAPC3orf11Tumor suppressor candidate 2Tumor suppressor 2, mitochondrial calcium regulator
02

Mechanism of action

Restoration of TUSC2 function leads to apoptosis in cancer cells (intrinsic apoptotic pathway upregulation). Regulates calcium homeostasis and mitochondrial function, affecting signaling pathways including EGFR, AKT, AMPK, p53, and others. Inhibits cell cycle progression and migration.

03

Biological functions

Cell cycle regulationApoptosis inductionSuppression of cell proliferationCalcium homeostasisRegulation of gene transcriptomeImmune response and inflammation modulation
04

Disease associations

Cancer (especially lung cancer, glioblastoma, breast, bone, and bladder cancers)Chronic inflammationInfection (bacterial, viral)Premature aging, geriatric diseases
05

Safety considerations

Toxicity depends on delivery method; phase I clinical studies of systemic TUSC2 gene therapy have reported manageable toxicities but require monitoring for immune reactions and off-target effectsGene therapy approaches using nanoparticles must be evaluated for inflammatory responses and long-term safety
06

Interacting drugs

No approved small-molecule drugs are known to directly target TUSC2.

1 more in the full profile.

07

Biomarkers

Loss of TUSC2 expression (by RT-PCR, IHC, or protein assays) in tumor tissues can serve as a biomarker for cancer diagnosis, prognosis, and therapy selection, especially in lung cancerRestoration levels following gene therapy can indicate biological activity

Beyond the preview

Go deeper on Tumor suppressor 2, mitochondrial calcium regulator (TUSC2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Tumor suppressor 2, mitochondrial calcium regulator (TUSC2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call